In MASH patients, β-arrestin2 expression in hepatic CD68+ Macrophages and circulating monocytes positively correlates with hepatic steatosis severity and the expression of M1 markers (IL-1β, NOS2). This evidence concerns the gene CD68 and metabolic dysfunction-associated steatohepatitis.